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Abstract
The capacity for Borrelia burgdorferi to cause disseminated infection in humans or mice is associated with the genotype of
the infecting strain. The cytokine profiles elicited by B. burgdorferi clinical isolates of different genotype (ribosomal spacer
type) groups were assessed in a human PBMC co-incubation model. RST1 isolates, which are more frequently associated
with disseminated Lyme disease in humans and mice, induced significantly higher levels of IFN-a and IFN-l1/IL29 relative to
RST3 isolates, which are less frequently associated with disseminated infection. No differences in the protein concentrations
of IFN-c, IL-1b, IL-6, IL-8, IL-10 or TNF-a were observed between isolates of differing genotype. The ability of B. burgdorferi to
induce type I and type III IFNs was completely dependent on the presence of linear plasmid (lp) 36. An lp36-deficient B.
burgdorferi mutant adhered to, and was internalized by, PBMCs and specific dendritic cell (DC) subsets less efficiently than
its isogenic B31 parent strain. The association defect with mDC1s and pDCs could be restored by complementation of the
mutant with the complete lp36. The RST1 clinical isolates studied were found to contain a 2.5-kB region, located in the distal
one-third of lp36, which was not present in any of the RST3 isolates tested. This divergent region of lp36 may encode one or
more factors required for optimal spirochetal recognition and the production of type I and type III IFNs by human DCs, thus
suggesting a potential role for DCs in the pathogenesis of B. burgdorferi infection.
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Introduction
Borrelia burgdorferi, a tick-transmitted spirochete, is the infectious
agent of Lyme disease [1,2]. This disease is a multisystemic
disorder with possible neurologic, rheumatologic, and cardiac
symptoms which develop following hematogenous dissemination
of the bacterium from the skin to distal target tissues [3]. The
potential for Lyme disease to develop from the bite of an infected
tick is highly variable due to the existence in nature of distinct B.
burgdorferi genotypes with diverse capacities to cause infection or to
disseminate. The genome of B. burgdorferi type strain B31-MI
consists of a single linear chromosome and 21 linear and circular
plasmids [4,5]. Linear plasmid 54 (lp54), circular plasmid 26 (cp26)
and the chromosome are highly conserved and have been present
in all tested natural isolates of B. burgdorferi. However, the presence
and content of other plasmids vary among isolates [4–7]. A
genotyping method for B. burgdorferi isolates based on restriction-
fragment length polymorphism of the 16S–23S ribosomal DNA
spacer region has been developed [8,9]. A relationship between
ribosomal spacer type (RST) and the capacity for disseminated
infection was observed; RST1 strains are more frequently
associated with disseminated infection in both Lyme disease
patients and mice, whereas RST3 isolates are less frequently
detected in the blood of patients and some do not disseminate in
mice [10–13]. The molecular mechanisms underlying the differ-
ential risk for hematogenous dissemination of different B. burgdorferi
genotypes, however, have not been elucidated.
B. burgdorferi induces the production of both pro- and anti-
inflammatory cytokines through the nuclear factor-kappa B (NF-
kB) signaling pathway [14–18]. Internalization of intact B.
burgdorferi and subsequent degradation and release of pathogen
associated molecular patterns (PAMPs) within the phagolysosome
are critical events leading to full activation of the innate immune
response to this extracellular pathogen [16,17,19–21]. Phagocytic
uptake of intact spirochetes induces secretion of IFN-c by NK cells
and triggers both apoptosis and the production of high levels of
pro-inflammatory cytokines by human monocytes [16,17]. Recent
findings have identified the endosomal receptors, TLR7 and
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TLR9 in dendritic cells, and TLR8 in monocytes, as pathogen
recognition receptors (PRRs) essential for the production of type I
IFN protein and the transcription of IFN-responsive genes by B.
burgdorferi-stimulated human immune cells [20–23]. Moreover,
Cervantes et al. provided evidence using human monocytes that
coordinated interactions between TLR8 and TLR2 facilitate the
development of a diverse pro- and anti-inflammatory cytokine
response by human monocytes [21]. However, despite the
contribution of TLR2 to the initiation of B. burgdorferi-triggered
signaling cascades both at the cell surface and within phagolyso-
somes, TLR2 is not required for spirochetal uptake [19]. Hawley
et al. recently identified CR3 (CD11b) as a MyD88-independent
phagocytic receptor for B. burgdorferi that also modulates TNF
production by murine bone marrow-derived macrophages [24].
The B. burgdorferi ligand for CR3, as well as spirochetal
components that mediate internalization by other phagocytic cell
populations, remain unknown.
Type I interferons (IFN-a/b), an innate defense classically
associated with an antiviral immune state and produced at high
levels by plasmacytoid dendritic cells (pDCs), are now known to be
induced in response to a variety of intracellular and extracellular
bacterial pathogens [20,25–29]. Previously, using an ex vivo co-
incubation model, we demonstrated that human pDCs and
CD11c+CD14+ monocytoid cells produce IFN-a protein following
phagocytosis of B. burgdorferi [20]. It has also been shown that IFN-
a is present at higher levels in the serum of Lyme disease patients
with multiple erythema migrans (EM) lesions, an indicator of
disseminated infection, compared to those of patients with a single
EM [26]. The expression of IFN-a in the EM lesion correlates
with the presence of monocytoid (mDC) and plasmacytoid (pDC)
dendritic cells, both of which are enriched approximately 5-fold in
the EM lesion infiltrate as compared with the skin of uninfected
controls [26]. The interactions of B. burgdorferi with a specific
innate immune cell population might facilitate dissemination and
promote Lyme disease pathogenesis.
The type III IFNs, or IFN-ls, discovered in 2003, are a family
of novel cytokines that includes three members: IFN-l1, IFN-l2,
and IFN-l3, also known as IL-29, IL-28A, and IL-28B,
respectively [30]. Similar to type I IFNs, IFN-ls are expressed
primarily by monocytes, macrophages, and dendritic cells, and can
be produced by these cells simultaneously with IFN-a and IFN-b
[30–33]. Although initially identified as anti-viral proteins, recent
studies demonstrate that type III IFNs are an important
component of the innate immune response to non-viral pathogens,
including Salmonella enterica serovar typhimurium [31,34] and Listeria
monocytogenes [35]. However, the expression pattern of the IFN-l
receptor (IFNlR) is far more restricted than that of the type I IFN
receptor; IFNlR is expressed solely in epithelial tissues and
epithelial-like cell types, suggesting that the effects exerted on
innate immunity likely are more important for pathogens
interacting with the epithelium [36,37]. Notably, L. monocytogenes
pathogenesis is promoted by type I IFNs but can be further
enhanced by cooperative interactions between type I IFNs and IL-
28B [35].
Two reports from our laboratory were the first to describe the
induction of IFN-l1 (IL-29) by B. burgdorferi [23,38]. Love et al.
demonstrated the production of IL-29 by TLR7-dependent
signaling in human PBMCs in response to live B. burgdorferi or
isolated B. burgdorferi RNA. Those results were generated using B.
burgdorferi B515, an RST1 clinical isolate that disseminates in mice
[11]. In the current study, the cytokine profiles induced by B.
burgdorferi clinical isolates of varying genotypes were analyzed using
a human PBMC ex vivo co-incubation model. Intriguingly,
differential recognition by human dendritic cells was found to be
dependent on a highly divergent region of lp36 which is conserved
among RST1 isolates.
Results
B. burgdorferi Clinical Isolates Induce Type I and Type III
IFNs in a Genotype-dependent Manner
B. burgdorferi clinical isolates obtained from the blood or skin
biopsies of early Lyme disease patients were classified into distinct
genotypes [9]. The interferon response of human PBMCs to B.
burgdorferi strains with varying genotypes was assessed using an ex
vivo co-incubation model as previously described [20,20] (Table 1).
IFN proteins in the cell-free culture supernatants were quantitated
by ELISA (IFN-a, IFN-l) or by cytometric bead array (IFN-c).
Representative results are shown in Figure 1. RST1 isolates
induced production of 224.706337.46 pg/mL of IFN-a, whereas
RST3 isolates induced 21.57614.86 pg/mL IFN-a (p = 0.012)
(Fig. 1A). In addition, RST1 isolates were also found to elicit
significantly higher production of IL-29/IFN-l1, a type III IFN, as
compared to RST3 isolates [RST1, 14.2868.41 pg/mL; RST3,
2.7860.24 pg/mL (p,0.01)] (Fig. 1B). In contrast, both RST1
and RST3 isolates induced equivalent amounts of IFN-c (Fig. 1C).
These results demonstrate that there is a significant correlation
between the induction of IFN-a and IFN–l1 and B. burgdorferi
genotype.
B. burgdorferi Isolates of Varying Genotypes Induce
Comparable Levels of Pro- and Anti-inflammatory
Cytokines
In order to better understand the role that genotype plays in the
B. burgdorferi-elicited cytokine response of human PBMCs, a
human FlowCytomix bead array was employed to simultaneously
measure various cytokine levels in cell-free culture supernatants
from 20-hour co-incubations of PBMCs with B. burgdorferi isolates
(Table 2). Protein levels for IL-1b, IL-6, IL-8 and TNF-a were the
highest of the cytokines measured. Concentrations of IL-10 and
IL-12p70 were markedly lower. IL-2, IL-4, IL-5 and TNF-b
proteins were below the level of detection in most of the samples
tested. No significant differences were detected when comparing
RST1- and RST3-induced levels of any of the cytokines (Table 2).
While it appeared that higher levels of IL-12p70 were induced by
RST1 isolates relative to RST3 isolates, this difference did not
achieve statistical significance (Table 2). In summary, of all
cytokine proteins assayed, only IFN-a and IFN-l1 levels differed
significantly in PBMCs incubated in the presence of B. burgdorferi
isolates of varying genotype, with higher induction by RST1
isolates.
B. burgdorferi Mutants Lacking Linear Plasmid 36 (lp36)
Elicit Virtually no IFN-a or IFN-l1
The sequenced B. burgdorferi genome of the B. burgdorferi type
strain B31-MI consists of a single linear chromosome and 12 linear
and 9 circular plasmids [4,5]. B31 is an RST1 strain [9]. B31-4 is a
derivative of strain B31 that lacks all linear plasmids [39]. This
strain elicited approximately 3.4664.17 pg/ml IFN-a protein,
whereas B31-A3, a strain that contains all plasmids, elicited
95.91658.91 pg/ml IFN-a (p = 0.02) (Figure 2A).
To identify the linear plasmid that may encode the factor(s)
responsible for type I IFN induction, B. burgdorferi mutants that
lacked single individual linear plasmids were assessed for their
ability to induce IFN-a. These included B31 strains which lacked:
lp28-1 [40], lp25 [40], two independent mutants lacking lp28-4
[41,42], and two independent mutants lacking lp36 [43]. The
B. burgdorferi lp36 Is Required for Type I IFN
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absence of lp28-1, lp25, and lp28-4 had no effect on IFN-a
production by human PBMCs (data not shown). However, the B.
burgdorferi strains which lacked only lp36 elicited virtually no IFN-a
protein. Results are shown in Figure 2A for A3-M9 lp362, a B31
derivative that lacks lp36 but contains all other plasmids known to
be required for infectivity [43]; an independently derived B31
strain lacking lp36 produced essentially identical results (data not
shown). A3-M9 lp362 elicited only 4.9364.95 pg/ml IFN-a
protein (p = 0.008) (Figure 2A). Furthermore, strain A3-M9 lp362
complemented by the re-introduction of lp36 (designated as A3-
M9 lp362/lp36+) [43] produced IFN-a at levels equivalent to
those induced by the parent strain B31-A3 (Figure 2A). B.
burgdorferi strains B31-4 and A3-M9 lp362 also elicited signifi-
cantly lower levels of IFN-l1 as compared to B31-A3
(2.5360.24 pg/mL and 2.9761.25 pg/mL vs. 11.6268.73 pg/
mL, respectively; p,0.001 for both) (Figure 2B). In contrast, IFN-
c, IL-1b, IL-6, IL-8, IL-10, and TNF-a production by PBMCs was
not dependent on lp36; B31-A3 and A3-M9 lp362 induced
comparable levels of these cytokines (Figure 2C and Table 3). This
finding suggests that a B. burgdorferi factor(s) required for induction
of type I and type III IFN is likely encoded on lp36.
Strains B31-A3 and A3-M9 lp362 elicit Virtually Identical
NF-kB-mediated Expression Profiles, but Differentially
Induce Type I IFN Gene Transcripts
In order to obtain a global picture of the NF-kB response
induced in human PBMCs exposed to B31-A3 or A3-M9 lp362,
PBMC total RNA was isolated following co-incubation and
analyzed using an NF-kB RT2 Profiler PCR Array. This allows for
the simultaneous quantitative measurement of 84 NF-kB-related
gene transcripts. Similar transcriptional response profiles were
generated by B31-A3 and A3-M9 lp362 (Figure 3). Genes which
were commonly induced by either strain $4-fold relative to
unstimulated PBMCs included those for IFN-c, IL-10, TNF-a, IL-
6, IL-1b, colony stimulating factor 3 (CSF3), complement factor B
(CFB), Fas ligand (FASLG) and nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor alpha (NFKBIA).
Genes which were commonly repressed by either isolate $4-fold
relative to unstimulated PBMCs consisted of those encoding NLR
family pyrin domain containing 12 (NLRP12), early growth
response 1 (EGR1) and FBJ murine osteosarcoma viral oncogene
homolog (FOS) (Figure 3A and 3B, respectively). Notably, genes
for the type I IFNs, IFNa1 and IFNb1, were uniquely induced
following PBMC stimulation with B31-A3 but not with A3-M9
lp362 (Figure 3A and 3B). A direct comparison of the expression
profiles elicited by B31-A3 and A3-M9 lp362 revealed that these
were the only two of the 84 genes on the NF-kB PCR array that
were differentially regulated by the two strains (Figure 3C). These
findings corroborate the IFN protein data shown in Figure 2 and
further validate the importance of lp36 for induction of the type I
IFN response.
Spirochetes that Lack lp36 have Reduced Adherence to
Human PBMCs and are Phagocytosed Less Efficiently
The production of IFN-a by B. burgdorferi-stimulated human
PBMCs is dependent on phagocytosis of the bacterium, as it is
blocked by the addition of cytochalasin D [20]. This suggested the
possibility that lp36-deficient B. burgdorferi failed to induce IFN-a as
a result of a defect in uptake of the mutant by phagocytic cells. To
test this hypothesis, B31, A3-M9 lp362 and A3-M9 lp362/lp36+
transformants containing green fluorescent protein (GFP) were
produced and their association with PBMCs was evaluated by flow
cytometry or microscopy. To verify that introduction of the GFP
reporter plasmid did not affect the ability to elicit type I IFN, the
GFP-transformed strains were assayed for IFN-a induction in
human PBMCs and were found not to differ significantly from the
non-GFP-transformed strains (data not shown). Adhesion and
association of GFP-tagged B31, A3-M9 lp362 and A3-M9
lp362/lp36+ that had been co-incubated with human PBMCs
Figure 1. RST1 isolates induce expression of multiple interfer-
ons. Human PBMCs (46106) were co-incubated for 20 hrs with RST1
(black bars) or RST3 (white bars) B. burgdorferi clinical isolates (46107)
(MOI = 10:1). Concentrations of human IFN-a (A), IFN-l1/IL29 (B), or IFN-
c (C) proteins in cell-free culture supernatants were quantitated by
ELISA (A,B) or cytometric bead array (C). Columns represent the mean6
SD of values from three blood donors assessed in independent
experiments, with the exception of (B) which represents results from a
single donor. Statistical analysis was performed using a non-parametric,
two-tailed Mann-Whitney U-test.
doi:10.1371/journal.pone.0100174.g001
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for 6 hr at either 4uC (prevents phagocytosis) or 37uC (allows
phagocytosis) were assessed by flow cytometry. A significantly
higher percentage of B31 adhered to PBMCs (3.960.2%GFP+
PBMCs vs. 1.5060.04%, p,0.001; 4uC), and associated with
PBMCs (3.8860.23% vs. 1.4860.04%GFP+ PBMCs, p,0.001;
37uC), than did A3-M9 lp362 (Figure 4A). A partial restoration in
adhesion and association was observed with the lp36-comple-
mented B. burgdorferi strain (Figure 4A).
The same co-incubation conditions were used to acquire
samples for 3D-fluorescence deconvolution microscopy (optical
sectioning) to further differentiate adherent from internalized
spirochetes. Cytocentrifugation was used to deposit cells from co-
incubations onto slides. Cells were fixed and stained with anti-
CD45, a pan-leukocyte marker, which labels the PBMC outer
membrane and allows the identification of spirochetes inside
PBMCs, as opposed to spirochetes adherent to the outside of the
cell membrane. Five 100X fields from three separate co-
incubations (B31 or A3-M9 lp362) at 37uC were analyzed.
Figure 4B shows a representative single optical section from a
deconvolved Z-stack for an adherent GFP-tagged B31 (left panel)
versus an internalized B31 B. burgdorferi (right panel). As shown in
Figure 4C, significant more wild type B. burgdorferi per field were
adherent to the outside of PBMCs as compared to lp362 mutants
(18.560.87 vs. 9.861.6 A3-M9 lp362; p,0.01). Similarly,
significantly more wild type spirochetes were internalized relative
to lp362 B. burgdorferi (17.364.4 vs. 3.061.2; p,0.05) (Figure 4C).
These data demonstrate that the absence of lp36 results in defects
in both B. burgdorferi spirochetal adhesion to, and internalization
by, PBMCs.
The Association of B. burgdorferi with mDC1s and pDCs is
Significantly Reduced when lp36 is Absent
PBMCs are a heterogeneous population of innate immune cells
consisting of T-cells, B- cells, monocytes, NK cells and dendritic
cells [44]. Human blood dendritic cells are classified as plasma-
cytoid dendritic cells (pDCs), myeloid BDCA1+ dendritic cells
(mDC1s) and myeloid BDCA3+ dendritic cells (mDC2s) [45].
Although pDCs constitute only ,0.4% of the total PBMC
population, they specialize in the production of large amounts of
type I IFNs [46,47]. Previous findings from this laboratory
demonstrated that pDCs and CD11c+CD14+ monocytoid cells are
the primary producers of IFN-a on co-incubation with B. burgdorferi
[20]. The cell population(s) involved in the differential association
and phagocytosis of B. burgdorferi based on the presence of lp36 was
further examined using flow cytometry (Figure 5). A significantly
higher percentage of BDCA1+ mDC1s (15.361.9 vs. 9.961.2; p,
0.01) and BDCA2+ pDCs (0.460.2 vs. 0.160.02; p,0.05) were
associated with GFP-tagged B31 B. burgdorferi than with the lp362
strain. Re-introduction of lp36 restored spirochetal association
with mDC1s and pDCs to levels observed with the wild type
Table 1. B. burgdorferi clinical isolates and strains used in this study.
Identifier Genotypea Biological source Reference
B31-A3 RST1 B31 derivative [101]
B31-4 RST1 B31 derivative [39]
A3-M9 lp362 RST1 B31 derivative [43]
A3-M9 lp362/lp36+ RST1 B31 derivative [43]
B479 RST1 Human EM skin biopsy [11]
B515 RST1 Human EM skin biopsy [11]
BL206 RST1 Lyme disease patient blood [10,11]
B331 RST3A Human EM skin biopsy [11]
B356 RST3A Human EM skin biopsy [10,11]
BL522 RST3A Lyme disease patient blood
BL630 RST3A Lyme disease patient blood
MR616 RST3A Human EM skin biopsy [7]
MR640 RST3A Human EM skin biopsy
MR676 RST3A Human EM skin biopsy
aGenotype was determined by PCR-RFLP analysis of 16S-23S ribosomal RNA gene spacer [9].
doi:10.1371/journal.pone.0100174.t001
Table 2. Pro- and anti-inflammatory cytokine production by RST1 and RST3 B. burgdorferi clinical isolates.
Cytokine (pg/mL)
Genotype IL-1b IL-6 IL-8 IL-10 IL-12p70 TNF-a
RST1* (n = 4) 2484167187 79738617430 73678621296 946861876 344163243 45748621388
RST3 (n = 6) 2189868148 71340610956 69671610190 980762641 239262728 43941618476
P value 0.317 0.479 0.826 0.788 0.137 0.981
*B31-4 and A3-M9 lp362 were not included in the RST1 group when calculating averages and performing statistical analysis. Statistical significance was determined
using a non-parametric Mann-Whitney U-test. Data shown are from three independent donors assessed in separate experiments.
doi:10.1371/journal.pone.0100174.t002
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(Figure 5A and 5B, respectively). However, it should be noted that
the percentages of pDCs associated with lp362 mutant or
complemented strains at 37uC were not significantly different.
Interestingly, both wild type and lp362deficient B. burgdorferi
strongly adhered to approximately 80% of BDCA3+ mDC2s at
4uC, but failed to associate with these cells at 37uC (Figure 5C),
although the total numbers of mDC2 cells remained unchanged
(Figure 5C, left). Together, these results demonstrate that lp36 is
required for optimal recognition and phagocytosis of spirochetes
by pDC and mDC1 populations.
RST1 Isolates contain a Region of lp36 which is Absent in
RST3A Isolates
It has been previously observed that plasmids constitute the
most divergent portion of the B. burgdorferi genome and that lp36 is
highly variable among clinical isolates of B. burgdorferi: the
divergent region of lp36 was shown to encompass ORFs
BBK35-BBK50 [7]. It was, therefore, of interest to explore
whether the presence or absence of this region of lp36 correlated
with the differential induction of IFN-a described earlier (Figure 1).
PCR primers (primer set lp36A; Table 4) were designed to amplify
a 2.5-kb sequence (bbk42-bbk45) within the divergent region of
lp36. The same four RST1 isolates and six RST3 isolates that were
tested for IFN-a production (Figure 1) were scored for the
presence of the lp36-divergent sequence. All RST1 isolates yielded
a PCR product of expected size, whereas no PCR product was
obtained for RST3 isolates (Figure 6A, top panel). The presence of
bbk19, which is located in a conserved area of lp36 adjacent to the
plasmid partition locus, was assessed to determine if the RST3
isolates lack the entire plasmid. All RST1 and four of the six RST3
isolates tested were PCR positive for bbk19; a bbk19 PCR product
was not detected for B356 or BL522 (Figure 6A, middle panel).
B356 was previously shown to lack lp36 [7]; the absence of bbk19
in BL522 suggests that this isolate may also lack lp36. All isolates
yielded a PCR product for ospA, which is located on the conserved
lp54 plasmid [7,48] (Figure 6A, bottom panel).
One limitation of PCR is the requirement that primer and
target DNA contain nucleotide sequences that are nearly 100%
complementary; even single nucleotide substitutions in the primer
binding sequence can substantially reduce primer annealing and
subsequent PCR product yield. Therefore, Southern hybridization
of SpeI-digested genomic DNA was performed for eight clinical
isolates using a gene probe specific for a 184-bp sequence located
within the 2.5-kB lp36 divergent region. These included three
RST1 and four RST3 isolates that had been assessed by PCR.
Due to insufficient yields of DNA, RST3 isolates MR676 and
MR640 could not be included; B331, an RST3 clinical isolate that
does not disseminate in mice [11], was substituted. The predicted
SpeI digestion fragment size of 3085 bp (lp36 nucleotide coordi-
nates 24828–27913) corresponding to the lp36 variable region was
observed in all three of the RST1 isolates but none of the RST3
isolates, confirming the PCR results (Figure 6B). These findings
suggest that the RST3 isolates studied possess an ‘lp36-like’
plasmid that lacks the divergent region conserved among RST1
isolates, and that this region of lp36 encodes the factor(s) required
for B. burgdorferi-elicited type I IFN production by human dendritic
cells.
Discussion
In this study, we used an established human PBMC ex vivo co-
incubation model [20] to explore the effect of B. burgdorferi
genotype on the induction of cytokines, including three major
classes of IFNs, and to delineate the host cell-pathogen interactions
that contribute to the differential induction of IFNs. We observed
that RST1 clinical isolates induced significantly higher levels of
IFN-a and IFN-l1 (IL-29) than did RST3 clinical isolates. In
contrast, there were no significant differences between these two B.
Figure 2. The presence of lp36 is required for IFN-a and IFN-l
induction. Human PBMCs (46106) were co-incubated for 20 hrs with
46107 wt B31-A3 (black bars), B31-4 (gray bars), A3-M9 lp362 (white
bars) or A3-M9 lp362/lp36+ (cross-hatched bar)(MOI = 10). Protein
concentrations of human IFN-a (A), IFN-l1 (B), or IFN-c (C) in cell-free
culture supernatants were quantitated by ELISA (A,B) or cytometric
bead array (C). The results are shown as the mean 6 SD of values from
three to five blood donors assessed in two or three independent
experiments. Statistics were obtained using a non-parametric Mann-
Whitney U-test.
doi:10.1371/journal.pone.0100174.g002
B. burgdorferi lp36 Is Required for Type I IFN
PLOS ONE | www.plosone.org 5 June 2014 | Volume 9 | Issue 6 | e100174
burgdorferi genotypes with regard to levels of induced IFN-c, IL-1b,
IL-6, IL-8, IL-10, IL-12p70 and TNF-a. Strle and colleagues
reported that B. burgdorferi RST1 isolates, OspC type A genotype in
particular, are associated with greater inflammation and more
severe disease [49]. After a 24-hour co-incubation of human
PBMCs with B. burgdorferi clinical isolates in that study, signifi-
cantly higher amounts of IL-6, IL-8, CCL3, and CCL4 were
produced in response to RST1 isolates as compared to those
incubated with RST2 or RST3 isolates. In addition, RST1 isolates
induced significantly higher levels of IFN-a than did RST2 isolates
[49]. There are several differences between the experiments
performed by Strle et al. and those described here that may
contribute to the contrasting results with regard to IL-6 and IL-8
production. Strle et al. used an MOI of 25:1 and co-incubation of
24 hours or 5 days, whereas an MOI of 10:1 and co-incubation for
20 hours were employed in this study. Importantly, despite some
differences, both studies demonstrate that there is a correlation
between B. burgdorferi genotype, the capacity to cause a dissemi-
nated infection and the ability to induce a type I IFN response.
The finding that the capacity of B. burgdorferi to induce a type I
and type III IFN response is genotype-dependent, and correlates
with pathogenic potential, raises a number of questions. One
important inquiry relates to the genomic component of B.
burgdorferi responsible for the differential IFN induction. The
genome of B. burgdorferi is comprised of a single linear chromosome
(,910 kb) and twelve linear and nine circular plasmids which total
an additional 610 kb [4,5]. There have been extensive studies
correlating plasmid content and the pathogenesis of B. burgdorferi
infection [40,41,43,50–53]. To identify the B. burgdorferi-encoded
factor(s) required for the induction of type I and type III IFNs,
various B. burgdorferi mutants lacking specific linear plasmids were
screened for their ability to induce a type I IFN response.
Strikingly, B. burgdorferi strains that selectively lacked only lp36 had
a significantly attenuated capacity to induce the production of type
I and type III IFNs. In contrast, both wild-type and lp36-deficient
B. burgdorferi induced comparable levels of IL-1b, -6, -8, -10, IL12-
p70, IFN-c and TNF-a. In support of these data, out of 84
different NF-kB-related genes, only the type I IFN gene transcripts
Table 3. Pro- and anti-inflammatory cytokine profiles elicited by B. burgdorferi B31-A3 and A3-M9 lp362.
Cytokine (pg/mL)
Genotype IL-1b IL-6 IL-8 IL-10 IL-12p70 TNF-a
B31-A3 (wt) 2112063259 112152671306 5436964144 859464851 916.96842.6 6688610922
A3-M9 lp362 1653569775 81210656966 50509612690 447561581 483.66687.8 297364324
P value 0.151 0.421 0.691 0.095 0.222 0.486
Statistical analysis was performed using a non-parametric Mann Whitney U-test. Data shown are from three to five independent donors assessed in separate
experiments.
doi:10.1371/journal.pone.0100174.t003
Figure 3. The absence of lp36 does not affect NF-kB-mediated signaling, but is required for transcription of ifna1 and ifnb1. Human
PBMCs (56106) were co-incubated for 12 hours with 56107 B31-A3 or A3-M9 lp362. Equal amounts of PBMC total RNA from each of three biological
replicates was pooled, converted to cDNA and used as a template for the Human NF-kB Signaling Pathway RT2 Profiler PCR Array. Genes that were
transcriptionally induced or repressed $4-fold are indicated by red or green circles, respectively. Scatter plots depict transcriptional regulation in
PBMCs stimulated with B31-A3 (A) or A3-M9 lp362 (B) versus unstimulated PBMCs. C, Comparison of transcript profiles of PBMCs stimulated with
either B31-A3 or A3-M9 lp362 B. burgdorferi.
doi:10.1371/journal.pone.0100174.g003
B. burgdorferi lp36 Is Required for Type I IFN
PLOS ONE | www.plosone.org 6 June 2014 | Volume 9 | Issue 6 | e100174
ifna1 and ifnb1 were found to be induced by wild-type B31-A3
relative to A3-M9 lp362.
The lp36 of B. burgdorferi type strain B31-MI is a 36-kilobase
plasmid that encodes 54 putative ORFs, many of which are
annotated as encoding hypothetical proteins [4]. There is a limited
body of literature regarding lp36 and its encoded ORFs. Using
whole cell DNA from a group of 15 North American B. burgdorferi
isolates, Palmer et al. determined that lp36-derived DNA probes
hybridized to targets of significantly different size in B31 as
compared to B31-MI [6]. Terekhova and colleagues performed
comparative genome hybridization and Southern blot analysis
with various clinical isolates of B. burgdorferi and determined that
RST1 isolates contain an lp36 plasmid virtually identical to that of
B31-MI, whereas the non-RST1 isolates contain an ‘‘lp36-like’’
plasmid that is considerably different from the lp36 of B31-MI, yet
contains the lp36 partition locus [7]. Jewett et al. investigated the
role of lp36 in the infectious cycle of B. burgdorferi and showed that
while lp36 was not required for spirochete survival in the tick, B.
burgdorferi lacking lp36 exhibited an approximately 4-log increase
in ID50 relative to wild-type B. burgdorferi in a murine infection
model [43]. The lower infectivity was partially attributed to the
loss of bbk17 (adeC), which encodes an adenine deaminase [43]. In
addition to bbk17, the functions of several other lp36-encoded
genes have been examined: bbk32 encodes a fibronectin-binding
protein that may promote full infectivity in mice [54–56], and
bbk07 has been investigated as a potential marker for serodiagnosis
of Lyme disease [57,58]. We tested mutant strains lacking bbk07,
bbk17 or bbk32 and found that these mutants induced IFN-a at
levels that were indistinguishable from those elicited by the wild-
type strain (data not shown). It is worthy to note that none of these
three genes is located within the divergent region (bbk35-bbk50) of
lp36.
The current investigation was designed to explore the relation-
ship between B. burgdorferi genotype and induction of a type I IFN
response. Rather than a systematic analysis of all OspC genotypes,
the study focused on RST1 (OspC type A) genotypes that have a
high probability of causing disseminated infection and RST3
strains with OspC genotypes (E, G, M and U) that have a low
Figure 4. The adhesion and uptake of B. burgdorferi is significantly reduced when lp36 is absent. Human PBMCs (46106) were co-
incubated with 46107 GFP-tagged B31-A3 (black bars), A3-M9 lp362 (white bars) or A3-M9 lp362/lp36+ (cross-hatched bars) for 6 hours at 4uC or
37uC. A, Flow cytometry was performed to compare the ability of the GFP-tagged B. burgdorferi strains to associate with PBMCs. Representative dot
plots are shown on the left. Graphs (right) depict the mean percentage 6 SD of PBMCs identified as FITC+, indicating either adhesion (4uC) or
adhesion and uptake (37uC) of GFP-tagged B. burgdorferi. Data are representative of results from three blood donors assessed in triplicate. A one-way
ANOVA with a Tukey’s post-test was used to determine statistical significance. B and C, Three-dimensional fluorescence deconvolution microscopy
was performed to quantify spirochetes adherent to, or internalized by, PBMCs. Samples were co-incubated with GFP-tagged B. burgdorferi for 6 hours
at 37uC. PBMC outer cell membranes were labeled with APC-conjugated anti-CD45 to label the outer cell membrane (cyan) and DAPI (blue) was used
to label the cell nucleus. Single optical sections of images acquired under 100X magnification were examined for adherent (B, left) or internalized (B,
right) GFP-tagged B. burgdorferi. C, Columns show the mean (6 SD) number of spirochetes outside (black bars) or inside (white bars) PBMCs. Data
were collected from single optical sections taken from five 100X fields from each of three independent biological replicates. An unpaired, two-tailed
Student’s t-test was used for statistical analysis.
doi:10.1371/journal.pone.0100174.g004
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Figure 5. lp36 contributes to the association of B. burgdorferi with specific populations of dendritic cells. Human PBMCs (46106) were
co-incubated with 46107 GFP-tagged B31 (black bars), A3-M9 lp362 (white bars) or A3-M9 lp362/lp36+ (cross-hatched bars) B. burgdorferi for 6
hours at 4uC or 37uC. The percentages of GFP+ mDC1s (CD192CD32BDCA22BDCA1+) (A), pDCs (CD192CD32BDCA2+BDCA12) or (B) mDC2s
(CD192CD32BDCA3+BDCA22) (C) were determined by multiparameter flow cytometry. Dot plots representing 500,000 collected events are provided
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probability of causing disseminated infection [59]. A limitation of
the study is that several RST2 and RST3 genotypes (OspC types
H, K and I) that have a high likelihood of producing disseminated
infection in humans were not analyzed. It would be of interest in a
future investigation to explore whether these B. burgdorferi
genotypes induce high levels of type I IFN by human PBMCs.
Recently, whole-genome sequences for other B. burgdorferi isolates
have become available [60] and provide further evidence for a
correlation between genotype, disseminating capacity and lp36
content. Strain N40, a B. burgdorferi OspC type E tick isolate that
disseminates in mice [61], contains sequences that are highly
homologous to the variable region of B31 lp36. However, the
genetic information is divided between lp17 and lp36: the last
,1400 nucleotides of the 2.5 kb fragment are present on N40 lp17
whereas the first ,800 nucleotides of the fragment remain on N40
lp36 [60]. In contrast, B. burgdorferi isolates 118a (OspC type J), 72a
(OspC type G) and 94a (OspC type U) [62,63], which based on
OspC type are likely to be RST3 isolates, do not encode the 2.5-kb
variable region of B31 lp36. Taken together, these data suggest
that this highly variable region may encode a factor(s) that is
responsible for the induction of type I and type III IFNs by human
PBMCs and that may contribute to the differential pathogenic
potential of RST1 and RST3 B. burgdorferi isolates.
We have previously demonstrated that B. burgdorferi induces
production of type I IFNs by human PBMCs in a TLR7- and
TLR9-dependent manner [20]. While generally host protective in
viral infections, the biological effects of type I IFNs on the outcome
of non-viral infections can be variable. A potent type I IFN
response contributes to the control of infection by some bacteria
[64–73] but promotes the pathogenesis of other bacteria, including
Listeria monocytogenes [25,74], Mycobacterium bovis [75], Mycobacterium
tuberculosis [76] and uropathogenic E. coli (UPEC) [77]. In the
context of B. burgdorferi infection, type I IFN signaling has been
shown to be crucial for the development of arthritis in a susceptible
mouse model [78,79]. In addition, significantly higher levels of
serum IFN-a have been detected in human patients with multiple
EM lesions, a symptom of disseminated B. burgdorferi infection, as
compared to patients with a single EM [26]. Similar to type I
IFNs, IFN-ls are expressed primarily by monocytes, macrophages
and dendritic cells and can be produced by these cells
simultaneously with IFN-a and IFN-b [30–33]. Type I and type
III IFNs possess overlapping biological activities: both can induce
MHC class I antigen expression, regulate transcription of a
common subset of interferon-stimulated genes in various cell lines
[30], increase NK and T cell cytotoxicity [80], promote Th1
responses [81] and mediate cellular apoptosis [82]. Recent studies
demonstrate that type III IFNs are an important component of the
innate immune response to non-viral pathogens, particularly those
that are associated with epithelial tissues, including Salmonella
enterica serovar typhimurium [31,34] and L. monocytogenes [35]. We
have previously shown that IFN-l1 production can be elicited
from human PBMCs by a disseminating isolate of B. burgdorferi, as
well as by purified RNA from this same isolate [23,23,38,38].
We have previously established that phagocytosis is required for
B. burgdorferi-induced IFN-a production by pDCs and mDC
precursors [20]. The finding that lp36 is required for the induction
of both type I and type III IFN suggests that lp36 may mediate the
association of B. burgdorferi with DC populations by encoding a
phagocytic ligand. This hypothesis is supported by multi-param-
eter flow cytometry and 3-D fluorescence deconvolution micros-
copy. B. burgdorferi that lacked lp36 were attenuated not only in the
ability to adhere to human PBMCs, but also in promoting
phagocytic uptake by these cells. The absence of lp36 did not
affect the ability of B. burgdorferi to either adhere to or associate
with mDC2s; it is therefore unlikely that this cell type has a critical
role in mediating spirochete dissemination. In contrast, optimal
association of B. burgdorferi with mDC1s and pDCs was found to be
to illustrate gating strategies (left). Column graphs represent the mean and standard deviation of three biological replicates (right). Statistical analysis
was performed using a one-way ANOVA with a Tukey’s post-test for multiple comparisons.
doi:10.1371/journal.pone.0100174.g005
Figure 6. RST1 isolates contain a region of lp36 that is lacking
in RST3 isolates. RST1 and RST3 B. burgdorferi isolates were grown to
late log phase prior to isolation of plasmid DNA. (A) PCR primers were
designed to amplify a ,2.5 kilobase region on the distal end of lp36.
The presence of lp36 was assessed by amplification of bbk19, an ORF
located adjacent to the plasmid partition locus. PCR products were
analyzed by gel electrophoresis in 1% agarose gels prepared in 1X TBE
buffer and stained with ethidium bromide. (B) Southern blotting of SpeI
digests of total genomic DNAs of B. burgdorferi isolates was performed
using a probe specific for the variable region of lp36 (upper panel). As a
control, membranes were stripped and re-probed for B. burgdorferi ospA
(BBA15), located on lp54 (lower panel).
doi:10.1371/journal.pone.0100174.g006
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dependent on the presence of lp36; thus these particular cells,
while comprising an extremely small percentage (,1%) of total
PBMCs, may preferentially associate with B. burgdorferi and aid the
spirochetes in hematogenous dissemination.
The data reported here support a conclusion that appears to be
paradoxical: B. burgdorferi with greater capacity for dissemination
are preferentially phagocytosed by DCs. However, a body of
literature has emerged that describes a crucial role for DCs in
immune suppression. Tolerogenic DCs have been shown to
promote the generation of regulatory T-cells (Tregs) through
expression of the immunosuppressive enzyme 2,3-indoleamine
dioxygenase (IDO) [83–86]. IDO expression has been implicated
in the generation of both central and peripheral tolerance, but a
particularly crucial function appears to be the establishment of
localized immune privilege in epithelial tissues. IDO-expressing
DCs and Foxp3+ Tregs have been implicated in the development
of various infectious and autoimmune pathological conditions of
the epithelium, including lichen planus, lupus vulgaris, sarcoidosis
and infections caused by Mycobacterium leprae, Haemophilus ducreyi,
UPEC and Leishmania sp. [77,87–91]. Of particular relevance to
the current study, Tregs have been found in the peripheral blood
of patients with secondary syphilis, a disease that evolves following
initial skin infection with Treponema pallidum, another spirochetal
pathogen [92]. Although it is known that human monocytoid and
plasmacytoid DCs are present in the EM lesion infiltrate of Lyme
disease patients [26,93,94], the potential role of these innate
immune cells in determining disease outcome remains to be
established. We hypothesize that recognition of B. burgdorferi by
DCs may direct the differentiation of these cells towards a
tolerogenic phenotype, resulting in localized immune suppression
that may be exploited by B. burgdorferi to establish infection and
enable dissemination. These questions are the topics of ongoing
investigation in our laboratory.
In summary, this study demonstrates that B. burgdorferi lp36 is
indispensable for the induction of IFN-a and IFN-l1 by human
PBMCs and for full recognition of B. burgdorferi by human dendritic
cell populations. In contrast, B. burgdorferi genotype did not affect
induction of IFN-c or other NF-kB-dependent cytokines. The
ability of B. burgdorferi to induce IFN-a and IFN-l was associated
with the presence of a variable 2.5-kb segment of lp36 (bbk42–
bbk45) that was conserved among the RST1 isolates, but absent in
all RST3 isolates evaluated. These results provide new insight into
the connection between B. burgdorferi genotype, lp36 content and
pathogenic potential. Although the presence of DCs in EM lesions
has been reported, the potential role of these innate immune cells
in determining disease outcome remains to be defined. The ability
of tolerogenic DCs to generate localized immune suppression
suggests a mechanism that may be exploited by B. burgdorferi in
order to establish infection and enable subsequent dissemination.
Materials and Methods
Ethics Statement
Written informed consent was obtained from all human subjects
in accordance with protocols approved by the Institutional Review
Board of New York Medical College.
Culture of Borrelia burgdorferi
Low-passage B. burgdorferi clinical isolates were obtained from
the blood or skin biopsies of the EM lesions of early Lyme disease
patients enrolled in a prospective study at the Lyme Disease
Diagnostic Center at New York Medical College, Valhalla, NY
[12,95]. B31-4, a derivative of B. burgdorferi strain B31 that lacks all
linear plasmids, has been described [39]. A3-M9 lp362 and A3-
M9 lp362/lp36+, both B31 derivative strains, have been
previously described [42]. Spirochetes were cultured in modified
Barbour-Stoenner-Kelly (BSK-S) medium [96]. To simulate the
temperature shifts that occur during tick-to-mammal transmission
and that may enhance the expression of virulence factors,
spirochetes were grown at 25uC, subcultured and incubated at
37uC until cultures reached the mid- to late-log phase of growth (4
to 86107/ml). Spirochetes were enumerated and assessed for
motility by dark-field microscopy [95]. The genotypes and
biological sources of the B. burgdorferi clinical isolates for which
data are reported in this study are provided in Table 1.
Isolation of Human PBMCs
Venous blood was obtained from five healthy adult volunteers
who had no prior history of Lyme disease, had not been
vaccinated for Lyme disease and were seronegative for B. burgdorferi
antibodies as confirmed by Western immunoblotting. Written
informed consent was obtained from all subjects before blood
collection, in accordance with the protocol approved by the
Institutional Review Board of New York Medical College. Blood
was collected directly into BD-Vacutainer CPT tubes (BD
Biosciences) and PBMCs were isolated by centrifugation according
to the manufacturer’s instructions. PBMCs were washed twice
with Hank’s Balanced Salt Solution (HBSS) and resuspended in
RPMI 1640 medium without phenol red containing 10% (v/v)
heat-inactivated and endotoxin-free fetal bovine serum (FBS)
(Hyclone). The viability of PBMCs was determined by trypan blue
staining and was found to be .90%.
Table 4. Oligonucleotides used for plasmid content analysis.
Primer name Primer sequence Predicted fragment size (bp) Plasmid nucleotide coordinates
lp36A-Forward 59-GGG AAA TGC TAT AAG CCT CAA GCC CAG CC-39 2480 26244–28724
lp36A-Reverse 59-GCT TAG CCT GCA CCA AGC TAT TGC TAA GG-39
lp36B-Forward 59-GCATCTCCTATAAGTATAC-39 184 27069–27253
lp36B-Reverse 59-TCCCTGGTAAAGTAATTCATTTATCC-39
BBK19-Forward 59-CTA TTG TTT GTC CAA GTC TTA ATC-39 1196 12269–13465
BBK19-Reverse 59-ATT GTA CGA AGT TGA ATT TTA GCA TC-39
OspA-Forward 59-GGG AAT AGG TCT AAT ATT AGC C-39 770 9410–10160
OspA-Reverse 59-TTT CAA CTG CTG ACC CCT C-39
doi:10.1371/journal.pone.0100174.t004
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Co-incubation of PBMCs with B. burgdorferi
Ex vivo stimulation of freshly isolated PBMCs by B. burgdorferi
was performed essentially as previously described [20]. Spirochetes
were centrifuged at 80006g for 10 min, washed twice with HBSS
and resuspended in RPMI 1640 without phenol red containing
10% (v/v) heat-inactivated and endotoxin-free FBS (Hyclone).
Live B. burgdorferi were added to 46106 (or 56106 for experiments
involving RNA isolation) viable PBMCs at a multiplicity of
infection (MOI) of 10:1 (spirochetes:PBMC) in 24-well tissue
culture plates, in a final volume of 1.1 ml. Co-cultures were
maintained in a humidified 37uC incubator containing 5% CO2
for the specified time period.
Measurement of Secreted Cytokine Proteins
PBMCs were co-incubated with B. burgdorferi for 20 hrs. Cell-
free culture supernatants were prepared by removal of PBMCs at
3006g for 10 min followed by centrifugation of the supernatant at
90006g for 10 min to remove non-adherent spirochetes and
cellular debris. Cell-free supernatants were aliquoted and stored at
220uC until further use. Concentrations of human IFN-a and
IFN–l1 were quantitated using the Human Verikine IFN-a (PBL
Biomedical Laboratories) or the Human IL-29 ELISA Ready-Set
Go! Kit (eBioscience), respectively. Protein levels of IFN-c, IL-1b,
IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 p70, TNF-a and TNF-b
in cell-free culture supernatants were measured using the
FlowCytomix Human Th1/Th2 11plex Kit (BMS810FF;Bender
MedSystems) according to the manufacturer’s instructions. Data
were acquired with a MACSQuant analyzer (Miltenyi Biotec) and
analyzed using FlowCytomix Pro Software (Bender MedSystems).
RNA Isolation
PBMCs were co-incubated with B. burgdorferi as described above
for 12 hours. The contents of each well were transferred to a 1.5-
ml microcentrifuge tube and centrifuged at 3006g for 5 min at
4uC. PBMCs were washed with HBSS and RNA was isolated
using the RNeasy Plus Mini Kit with QIAshredder and gDNA
eliminator columns (Qiagen). RNA was eluted in 20 ml of RNase/
DNase-free water and stored at 280uC after the addition of 0.8 ml
of RNase inhibitor (40 U/ml; Promega).
NF-kB-mediated Gene Expression PCR Array
PBMCs were co-incubated in triplicate with B. burgdorferi for
12 hr and RNA was isolated as described above. The RT2 First
Strand Kit (SABiosciences) was used for cDNA synthesis,
according to the manufacturer’s instructions. cDNA from biolog-
ical triplicates was pooled and used as a template for the RT2
Profiler PCR Array Human NFkB Signaling Pathway (PAHS-
025A;SABiosciences), according to the manufacturer’s instruc-
tions. This array contains primer pairs for 84 well-characterized
NF-kB-related genes, 5 housekeeping genes and various quality
controls in a 96-well plate format. Transcript levels were
quantified based on the 22DDCT method [97] through the
measurement of SYBR green fluorescence using the RT2 Real-
Time SYBR Green/Rox PCR Master Mix (PA-012; SABios-
ciences).
Generation of Green Fluorescent Protein-expressing B.
burgdorferi
A GFP reporter plasmid, based on plasmid pCE320 [17,98],
was used to electrotransform B. burgdorferi A3-M9 lp362 B.
burgdorferi as previously described [99]. This plasmid contains the
GFP structural gene fused to the constitutive flaB promoter of B.
burgdorferi and encodes for gentamicin resistance. Transformants
were selected by growth in BSK medium containing 40 mg/mL of
gentamicin and plated by limiting dilution to obtain single clones.
The GFP-expressing lp36 complement, A3-M9 lp362/lp36+, was
constructed using the GFP reporter plasmid pSPC-S [100]. This
plasmid contains the GFP structural gene fused to the constitutive
flaB promoter of B. burgdorferi and encodes for streptomycin
resistance. Transformants were selected by growth in BSK-S
medium containing 100 mg/mL streptomycin. Wild-type B31 B.
burgdorferi expressing GFP was kindly provided by Drs. Justin
Radolf and Melissa Caimano, University of Connecticut Health
Center [98].
Multi-parameter Flow Cytometric Analysis
Human PBMCs were co-incubated for 6 hours at 4uC or 37uC
with GFP-tagged B. burgdorferi at MOI of 10. Following co-
incubation, the contents of each well were transferred to a 5 mL
FACS tube and pelleted at 3006g for 10 min. Cells were washed
twice with 1 mL HBSS to remove unattached spirochetes, fixed
with 3.2% formaldehyde in HBSS for 30 min, pelleted and
resuspended in 0.5 mL FACS stain buffer (1X PBS, 0.2% bovine
serum albumin, pH 7.4). Total numbers of GFP+ PBMCs were
determined by flow cytometric analysis of 100,000 to 300,000
events using a MACSQuant Analyzer and MACSQuantify
software (Miltenyi Biotec).
Dendritic cell populations present within PBMCs were identi-
fied by labeling of surface antigens. Following co-incubation, the
contents of each well were transferred to two, 5 mL FACS tubes
(,26106 cells each) and centrifuged at 3006g for 10 min. Cells
were washed once with 1 ml HBSS and once with 1 ml FACS
stain buffer. To block Fc receptors, cells were resuspended in 70 ml
stain buffer containing 1 mg/mL human IgG1, kappa, purified
myeloma protein (Sigma 5154). 30 mL of the appropriate antibody
staining panel (mDC1/pDC or mDC2) was then added to each
sample. Antibody fluorochrome conjugates consisted of anti-
CD19-eFluor450 (mouse IgG1,k, clone HIB19 eBioscience 48-
0199), anti-CD3-eFluor450 (mouse IgG1,k, clone UCHTI
eBioscience 48-0038), anti-BDCA1 (CD1c)-APC (mouse IgG2a,
clone AD5-8E7 Miltenyi 130-090-903), anti-BDCA2 (CD303)-PE
(mouse IgG1, clone AC144 Miltenyi 130-090-511) and anti-
BDCA3 (CD141)-APC (mouse IgG1, clone AD5-14H12 Miltenyi
130-090-907). Cell populations were defined as follows: mDC1s
(CD192CD32BDCA22BDCA1+), pDCs
(CD192CD32BDCA2+BDCA12) or mDC2s
(CD192CD32BDCA3+BDCA22). Samples were mixed well,
covered and refrigerated at 4–8uC for 10 min. Cells were washed
by adding 2 mL stain buffer followed by centrifugation at 3006g
for 10 min at 4uC. Cells were then fixed in 800 mL of 3.2%
formaldehyde in HBSS, covered and stored overnight at 4–8uC.
Following fixation, cells were pelleted at 3006g for 10 min at 4–
8uC and resuspended in 500 mL stain buffer. A minimum of
500,000 events per sample were collected on a MACSQuant
analyzer and analyzed using MACSQuantify software (Miltenyi).
Quantitation of Internalized versus Extracellular
Spirochetes using 3-D-fluorescence Deconvolution
Microscopy
Human PBMCs were co-incubated with GFP-tagged B.
burgdorferi for 6 hours at 4uC or 37uC. Cells were pelleted at
3006g for 5 minutes, washed twice with tissue culture grade 1X
PBS to remove non-adherent spirochetes and deposited onto glass
microscope slides by cytocentrifugation. Cells were fixed in 3.7%
formaldehyde for 20 minutes and stored in 1X PBS overnight at
4uC. Cells were protected from light and stained for 1 hour at
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room temperature with APC-conjugated mouse anti-CD45 (cyan)
(Invitrogen; MHCD4505), a pan-leukocyte cell membrane mark-
er, to define the PBMC outer membrane. Coverslips were
mounted using Vectashield containing DAPI (Vector Laborato-
ries, Inc.). Counts were obtained from deconvolved images using
an inverse filter algorithm. Five 100X fields (,250 total PBMCs)
from each of three independent co-incubations were examined in
a blinded manner for adherent or internalized spirochetes.
Samples were imaged on a Zeiss Axiovert 200 fluorescence
microscope and data were analyzed using Axiovision 4.6.3
software (both from Carl Zeiss, Inc.).
PCR Analysis of B. burgdorferi Linear Plasmid Sequences
Plasmid DNA was isolated from 4-ml B. burgdorferi cultures
(16107 to 16108 cells/ml) with the Qiaprep Spin Miniprep kit
(Qiagen) and resuspended in 30 ml of nuclease-free water. PCR
primers (Table 4) were designed to amplify a 2.5-kB sequence on
lp36, encompassing bbk42–bbk45 [7,62]. Each PCR mixture
contained approximately 10 ng DNA, 250 mM deoxynucleoside
triphosphates (Roche), 10 ng of each primer and 1 U Taq DNA
polymerase (Denville Scientific, Inc.). PCR conditions were as
follows: initial denaturation at 95uC for 3 minutes; 35 cycles of
95uC for 1 minute, 60uC for 40 seconds, 72uC for 3 minutes; and
final extension at 72uC for 2 minutes. PCR of bbk19 was
performed to assess the presence or absence of lp36. PCR
parameters were as follows: initial denaturation at 95uC for 3
minutes, followed by 35 cycles of 95uC for 30 seconds, 48uC for 30
seconds, 72uC for 3 minutes, and final extension at 72uC for 2
minutes. ospA (bba15) was amplified as a control for the presence of
plasmid DNA using the following conditions: initial denaturation
at 95uC for 3 minutes; followed by 35 cycles of 95uC for 30
seconds, 52uC for 30 seconds, 72uC for 3 minutes; and final
extension at 72uC for 2 minutes. PCR products were analyzed by
electrophoresis in 1% agarose gels prepared in 1X TBE buffer and
stained with ethidium bromide.
Southern Hybridization
Total DNA was isolated from 10-ml cultures of B. burgdorferi
B31-MI using a commercial DNA extraction kit (DNeasy Blood
and Tissue Kit; Qiagen) and suspended in 100 ml nuclease-free
water. DNA (3 mg) was digested overnight at 37uC with SpeI
(10 U) in 50 mL 1X Buffer 2 (New England Biolabs) supplemented
with 100 mg/ml BSA. Digested DNA was separated by electro-
phoresis on a 1% agarose gel prepared in 1X TBE buffer.
Probes to ospA and lp36 were separately generated by PCR
using 10 ng B31-MI DNA template and 10 ng of each primer
(Table 4). PCR parameters for bba15 (ospA) were as previously
reported [48]. A 184-bp sequence located in the divergent region
of lp36 was amplified using the lp36-B primer set and the following
thermocycler conditions: initial denaturation at 95uC for 2
minutes; 35 cycles of 94uC for 30 seconds, 42uC for 30 seconds
and 72uC for 30 seconds; and final extension at 72uC for 2
minutes. PCR products were purified using a commercial kit
(Qiagen) and labeled with digoxygenin-11-dUTP according to the
manufacturer’s protocol (Roche Molecular Biochemicals). South-
ern blotting was performed as previously described [48].
Hybridization was first performed for the lp36 sequence.
Hybridization patterns were visualized by addition of CDP-Star
chemiluminescent substrate (Sigma-Aldrich) followed by exposure
of the membrane to radiographic film for 2 to 4 minutes. The
membrane was then stripped and re-probed for ospA.
Statistical Analysis
Statistical significance was determined by one-way Analysis of
Variance (ANOVA), a non-parametric Mann-Whitney U-test, a
Kruskal-Wallis test, or a two-tailed, unpaired Student’s t-test using
GraphPad Prism 5 software (GraphPad Software, Inc.), as
appropriate.
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